We reasoned that given the requirement of MSH2 for repeat contractions in FXS ESCs, transient plasmid-derived expression of TET1 in MSH2 KO FXS ESCs might allow us to reactivate the gene without generating contractions. The gene discussed is MSH2; the disease is fragile X syndrome.